Tag: At-home therapy
-
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder: Proliv™Rx
Overview: A new option for major depressive disorder The U.S. Food and Drug Administration (FDA) has cleared Proliv™Rx, an at-home neuromodulation device, for use as an adjunctive treatment for adults with major depressive disorder (MDD) who have not achieved satisfactory improvement after at least one previous therapy. This marks a notable milestone in the growing…
-
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder
FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder The U.S. Food and Drug Administration has cleared Proliv™Rx, an at-home neuromodulation therapy, to be used as an adjunctive treatment for adults diagnosed with major depressive disorder (MDD) who have not achieved satisfactory improvement after at least one prior antidepressant. The approval marks a notable milestone…